-- 根据周一提交给澳大利亚证券交易所的文件显示,Island Pharmaceuticals(ASX:ILA)与美国陆军传染病医学研究所(USAMRIID)和德克萨斯生物医学研究所的合作进展顺利,其候选药物Galidesivir的下一阶段临床开发预计很快启动。 该公司根据澳大利亚政府2025财年的研发税收优惠政策,获得了约14.3万澳元的退税。该退税与ISLA-101的持续开发相关的合格支出有关。 在今年3月季度,该公司与Todd Strategy Group和MC2合作,推进了在美国的行业合作计划。 文件补充道,Galidesivir是一种处于临床阶段的抗病毒分子,对包括埃博拉病毒、马尔堡病毒、中东呼吸综合征病毒、寨卡病毒和黄热病病毒在内的20多种RNA病毒具有广谱活性。 该公司股价在周一的交易中上涨了1%。
Related Articles
Black Diamond Group's Revolving Credit Facility Upsized to C$550 Million from C$425 Million
Black Diamond Group's (BDI.TO) secured, asset-based, revolving credit facility has been upsized to C$550 million from $425 million, the company said Monday.The uncommitted accordion of $75 million, the interest rate pricing grid and other major terms including financial covenants remained unchanged, Black Diamond said."Upsizing our asset-based credit facility provides us with additional liquidity to continue pursuing our accretive growth objectives as we scale the business," Chief Financial Officer Toby LaBrie said.Black Diamond is an industrial services and asset management company that operates in Canada, U.S. and Australia through its modular space solutions and workforce solutions business units.
Global Power Solutions Signs Non-Binding LOI to Evaluate Development of Modular Hydrogen-Powered Energy Project
Global Power Solutions (PWER.V) entered into a non-binding Letter of Intent (LOI) with 2782404 AB LTD to evaluate the potential development of a modular hydrogen-powered energy project, it said Monday.The parties, under the terms of the LOI, will undertake a technical, commercial, and regulatory feasibility review to evaluate the potential development of one or more modular facilities with a potential aggregate capacity of up to about 100 megawatts. The proposed project, if advanced following feasibility review and definitive agreements, could be developed in phased stages."This LOI represents an opportunity to evaluate a potential application of modular hydrogen-powered energy systems within a decentralized generation framework," said Global Power Solutions Chief Executive Peter Medved. "The feasibility process will allow both parties to assess technical configuration, commercial structure, and regulatory considerations before determining whether to proceed toward definitive agreements."The company may establish project-level special purpose entities (SPEs) for the development, ownership, financing, and operation of any project facilities. 2782404 is expected to provide site access information, operational requirements, and anticipated power demand profiles to support the feasibility assessment, while Global is expected to lead the technical evaluation and project development planning.The parties also anticipate that the feasibility process will include engineering studies, site suitability assessments, preliminary financial modeling, and evaluation of hydrogen production, storage, and power generation configurations. If the project proceeds beyond feasibility, the parties, it added, may negotiate a long-term power purchase agreement under which electricity generated by the project could potentially be supplied to 2782404 under a defined commercial framework.Shares of the company closed up 10% to $0.32 on Friday on the TSX Venture Exchange.
Brookfield Asset Management Price Target Lowered By US$6 at TD
TD Securities lowered its price target on Brookfield Asset Management Ltd. (BAM.TO, BAM) to US$69 from US$75 on Monday.Analyst Cherilyn Radbourne maintained a Buy rating on shares of the Toronto-based global alternative asset manager ahead of its Q1 results on May 8."Amid cautious investor sentiment on the alt managers, BAM offers a highly resilient/diversified FRE-driven earnings profile, anchored in real assets," Radbourne said in a note to clients."BAM has minimal software exposure, and meaningful scale/experience in power, which enables it to offer a truly differentiated AI backbone solution," the analyst said."Upcoming first closes on three flagship funds offer potential catalysts."(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)